Healthcare / Medical Care FacilitiesTokyo
$1235.00
-77.00 (-5.78%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 17%
FCF escenarios
weak_data · normalized FCF $411.9M · quality 33.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
39/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$9.3B
P/E
13.1x
↓EV/EBITDA
9.8x
↓ROE
26.4%
↑Gross Margin
27.5%
↓Debt/Equity
1.42
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2024 · 2 años de histórico normalizado
Revenue CAGR
+7.8%
FCF CAGR
—
FCF margin
8.3%
FCF / Net income
0.74x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.99B · net income $558.4M · FCF $411.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $4.99B | $4.99B | $4.65B | $4.30B |
| Net Income | $558.4M | $558.4M | $506.1M | $316.9M |
| EBITDA | $1.16B | $1.16B | $1.13B | $865.6M |
| EPS | — | — | 68.17 | 42.40 |
| Gross Margin | 27.5% | 27.5% | 27.6% | 28.4% |
| Operating Margin | 16.6% | 16.6% | 17.3% | 16.8% |
| Net Margin | 11.2% | 11.2% | 10.9% | 7.4% |
| Balance Sheet | ||||
| Debt/Equity | 1.42 | 1.42 | 2.12 | 3.14 |
| Current Ratio | 1.27 | 1.27 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $411.9M | $411.9M | $458.6M | $-1.06B |
| Returns | ||||
| ROE | 26.4% | 26.4% | 33.3% | 31.3% |
| Valuation | ||||
| P/E | 13.12 | 13.12 | — | — |
| EV/EBITDA | 9.76 | 9.76 | — | — |
| P/B | 4.37 | 4.37 | — | — |
| Growth & Yield | ||||
| Revenue Growth | 7.3% | 7.3% | 8.3% | — |
| EPS Growth | — | — | 60.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+75.5%
Start / end P/E
n/dx → n/dx
EPS bridge
68.17 → n/d
Residual
+75.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.